|
|||||
|
|
Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy |
|
| Authors: | Ajai Chari Dan T. Vogl Sundar Jagannath Jagoda Jasielec Thaddeus J. Unger Andrew DeCastro Jatin Shah Michael Kauffman Sharon Shacham Andrzej Jakubowiak |
| Affiliation: | 1. Icahn School of Medicine at Mount Sanai, New York, NY, USA;2. Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA;3. University of Chicago Medical Center, Chicago, IL, USA;4. Karyopharm Therapeutics, Newton, MA, USA |
| Abstract: | |
| Keywords: | selinexor chimeric antigen receptor T cell refractory multiple myeloma carfilomib bortezomib |